Key result
Modern in vivo imaging techniques for assessing epicardial adipose tissue highlight its prospective association with the onset and progression of coronary heart disease and atrial fibrillation.
Why the study?
Epicardial fat plays a role in cardiovascular disease progression, and its accumulation is prospectively associated with coronary heart disease and atrial fibrillation.
This review highlights modern non-invasive imaging techniques for assessing epicardial adipose tissue and its association with cardiovascular diseases.
May aid risk stratification in CHD and AF; leaves open whether modulating epicardial fat alters progression.
Epicardial adipose tissue (EAT) is a visceral depot of the heart fat, which has high plasticity and directly contact with the myocardium and coronary arteries. Epicardial fat is a unique paracrine organ closely anatomically and physiologically related to the myocardium. Recent studies have repeatedly confirmed the role of epicardial fat in the progression of the cardiovascular diseases. The accumulation of EAT, measured by using new non-invasive imaging techniques, is prospectively associated with the onset and progression of coronary heart disease (CHD) and atrial fibrillation. This review focuses on modernin vivomethods for assessing epicardial fat.
No takes yet. Share an insight, caveat, or question.
Vasilkova et al. (2023) conducted a review in Cardiovascular diseases. In vivo methods for assessing epicardial fat was evaluated. Modern in vivo imaging techniques for assessing epicardial adipose tissue highlight its prospective association with the onset and progression of coronary heart disease and atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: